Logo image of HLNE

HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis

USA - NASDAQ:HLNE - US4074971064 - Common Stock

121.63 USD
-3.29 (-2.63%)
Last: 10/15/2025, 12:00:57 PM
Fundamental Rating

6

Overall HLNE gets a fundamental rating of 6 out of 10. We evaluated HLNE against 237 industry peers in the Capital Markets industry. HLNE scores excellent on profitability, but there are some minor concerns on its financial health. HLNE is valued quite expensively, but it does show have an excellent growth rating. With these ratings, HLNE could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

HLNE had positive earnings in the past year.
In the past year HLNE had a positive cash flow from operations.
In the past 5 years HLNE has always been profitable.
HLNE had a positive operating cash flow in each of the past 5 years.
HLNE Yearly Net Income VS EBIT VS OCF VS FCFHLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

HLNE has a better Return On Assets (11.78%) than 91.98% of its industry peers.
The Return On Equity of HLNE (27.96%) is better than 94.51% of its industry peers.
HLNE has a Return On Invested Capital of 18.59%. This is amongst the best in the industry. HLNE outperforms 95.36% of its industry peers.
HLNE had an Average Return On Invested Capital over the past 3 years of 22.58%. This is significantly above the industry average of 7.58%.
Industry RankSector Rank
ROA 11.78%
ROE 27.96%
ROIC 18.59%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
HLNE Yearly ROA, ROE, ROICHLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

1.3 Margins

Looking at the Profit Margin, with a value of 30.66%, HLNE is in the better half of the industry, outperforming 76.37% of the companies in the same industry.
In the last couple of years the Profit Margin of HLNE has grown nicely.
HLNE has a better Operating Margin (43.91%) than 78.06% of its industry peers.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
Industry RankSector Rank
OM 43.91%
PM (TTM) 30.66%
GM N/A
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
HLNE Yearly Profit, Operating, Gross MarginsHLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

6

2. Health

2.1 Basic Checks

The number of shares outstanding for HLNE has been increased compared to 1 year ago.
Compared to 5 years ago, HLNE has more shares outstanding
HLNE has a worse debt/assets ratio than last year.
HLNE Yearly Shares OutstandingHLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
HLNE Yearly Total Debt VS Total AssetsHLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

HLNE has an Altman-Z score of 5.37. This indicates that HLNE is financially healthy and has little risk of bankruptcy at the moment.
HLNE has a Altman-Z score of 5.37. This is amongst the best in the industry. HLNE outperforms 86.92% of its industry peers.
The Debt to FCF ratio of HLNE is 0.85, which is an excellent value as it means it would take HLNE, only 0.85 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HLNE (0.85) is better than 90.72% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that HLNE is not too dependend on debt financing.
HLNE has a Debt to Equity ratio of 0.38. This is in the better half of the industry: HLNE outperforms 68.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.85
Altman-Z 5.37
ROIC/WACCN/A
WACCN/A
HLNE Yearly LT Debt VS Equity VS FCFHLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, HLNE is in line with its industry, outperforming 53.59% of the companies in the same industry.
HLNE has a Quick Ratio of 1.16. This is a normal value and indicates that HLNE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.16, HLNE perfoms like the industry average, outperforming 54.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
HLNE Yearly Current Assets VS Current LiabilitesHLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. Growth

3.1 Past

HLNE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.80%.
The Earnings Per Share has been growing by 20.18% on average over the past years. This is a very strong growth
Looking at the last year, HLNE shows a quite strong growth in Revenue. The Revenue has grown by 10.65% in the last year.
Measured over the past years, HLNE shows a very strong growth in Revenue. The Revenue has been growing by 21.08% on average per year.
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
Revenue 1Y (TTM)10.65%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%

3.2 Future

The Earnings Per Share is expected to grow by 14.01% on average over the next years. This is quite good.
HLNE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.52% yearly.
EPS Next Y-0.5%
EPS Next 2Y9.95%
EPS Next 3Y14.01%
EPS Next 5YN/A
Revenue Next Year7.46%
Revenue Next 2Y12.27%
Revenue Next 3Y14.52%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HLNE Yearly Revenue VS EstimatesHLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HLNE Yearly EPS VS EstimatesHLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.13 indicates a quite expensive valuation of HLNE.
Compared to the rest of the industry, the Price/Earnings ratio of HLNE indicates a slightly more expensive valuation: HLNE is more expensive than 66.67% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.49. HLNE is around the same levels.
With a Price/Forward Earnings ratio of 19.96, HLNE is valued on the expensive side.
HLNE's Price/Forward Earnings ratio is in line with the industry average.
HLNE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.13
Fwd PE 19.96
HLNE Price Earnings VS Forward Price EarningsHLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

HLNE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HLNE is cheaper than 69.20% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as HLNE.
Industry RankSector Rank
P/FCF 20.05
EV/EBITDA 22.12
HLNE Per share dataHLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of HLNE may justify a higher PE ratio.
HLNE's earnings are expected to grow with 14.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1.25
EPS Next 2Y9.95%
EPS Next 3Y14.01%

4

5. Dividend

5.1 Amount

HLNE has a Yearly Dividend Yield of 1.82%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 8.33, HLNE is paying slightly less dividend.
HLNE's Dividend Yield is slightly below the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 1.82%

5.2 History

On average, the dividend of HLNE grows each year by 19.56%, which is quite nice.
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
HLNE Yearly Dividends per shareHLNE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

HLNE pays out 37.04% of its income as dividend. This is a sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP37.04%
EPS Next 2Y9.95%
EPS Next 3Y14.01%
HLNE Yearly Income VS Free CF VS DividendHLNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HLNE Dividend Payout.HLNE Dividend Payout, showing the Payout Ratio.HLNE Dividend Payout.PayoutRetained Earnings

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (10/15/2025, 12:00:57 PM)

121.63

-3.29 (-2.63%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners96.85%
Inst Owner Change-0.02%
Ins Owners7.22%
Ins Owner Change-2.89%
Market Cap6.78B
Analysts50.91
Price Target168.71 (38.71%)
Short Float %6.23%
Short Ratio6.62
Dividend
Industry RankSector Rank
Dividend Yield 1.82%
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP37.04%
Div Incr Years7
Div Non Decr Years7
Ex-Date09-19 2025-09-19 (0.54)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.26%
Min EPS beat(2)1.1%
Max EPS beat(2)27.41%
EPS beat(4)3
Avg EPS beat(4)9.11%
Min EPS beat(4)-3.63%
Max EPS beat(4)27.41%
EPS beat(8)5
Avg EPS beat(8)9.21%
EPS beat(12)8
Avg EPS beat(12)10.1%
EPS beat(16)12
Avg EPS beat(16)13.17%
Revenue beat(2)2
Avg Revenue beat(2)7.35%
Min Revenue beat(2)1.01%
Max Revenue beat(2)13.69%
Revenue beat(4)3
Avg Revenue beat(4)3.94%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)13.69%
Revenue beat(8)5
Avg Revenue beat(8)7.81%
Revenue beat(12)7
Avg Revenue beat(12)8.52%
Revenue beat(16)9
Avg Revenue beat(16)8.28%
PT rev (1m)1.6%
PT rev (3m)5.57%
EPS NQ rev (1m)-1.74%
EPS NQ rev (3m)5.64%
EPS NY rev (1m)0%
EPS NY rev (3m)9.85%
Revenue NQ rev (1m)-1.27%
Revenue NQ rev (3m)4.6%
Revenue NY rev (1m)-0.92%
Revenue NY rev (3m)5.08%
Valuation
Industry RankSector Rank
PE 25.13
Fwd PE 19.96
P/S 9.79
P/FCF 20.05
P/OCF 19.36
P/B 8.93
P/tB 8.93
EV/EBITDA 22.12
EPS(TTM)4.84
EY3.98%
EPS(NY)6.09
Fwd EY5.01%
FCF(TTM)6.07
FCFY4.99%
OCF(TTM)6.28
OCFY5.16%
SpS12.42
BVpS13.62
TBVpS13.62
PEG (NY)N/A
PEG (5Y)1.25
Profitability
Industry RankSector Rank
ROA 11.78%
ROE 27.96%
ROCE 22.22%
ROIC 18.59%
ROICexc 24.17%
ROICexgc 24.88%
OM 43.91%
PM (TTM) 30.66%
GM N/A
FCFM 48.83%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexcg growth 3Y19.01%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.85
Debt/EBITDA 0.92
Cap/Depr 126.25%
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion 111.67%
Profit Quality 159.29%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 5.37
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
EPS Next Y-0.5%
EPS Next 2Y9.95%
EPS Next 3Y14.01%
EPS Next 5YN/A
Revenue 1Y (TTM)10.65%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%
Revenue Next Year7.46%
Revenue Next 2Y12.27%
Revenue Next 3Y14.52%
Revenue Next 5YN/A
EBIT growth 1Y8.35%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year7.75%
EBIT Next 3Y14%
EBIT Next 5YN/A
FCF growth 1Y55.62%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y56.53%
OCF growth 3Y21.07%
OCF growth 5Y20.91%